Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Titan Meds Platform is a telehealth-based healthcare company specializing in men's hormone optimization and testosterone replacement therapy (TRT). Operating as a subsidiary of Thirty Madison, the company provides a lab-guided care pathway that includes online blood testing, licensed clinician consultations, and home delivery of prescribed medications. Its offerings include injectable and oral testosterone, enclomiphene, and other supportive therapies such as anastrozole. The platform aims to streamline access to specialized hormone care through a digital-first approach, integrating administrative, logistical, and clinical coordination. Titan Meds Platform LLC manages the technology and operations, while clinical care is delivered through a network of independent medical groups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Titan Meds Platform.